Raiffeisen Bank International AG .../ AT0000A3CLJ8 /
| 28.02.2025 0:00:00 | Изменение-0.05 | Бид- | Предложение- | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
|---|---|---|---|---|---|---|---|
| 6.17EUR | -0.80% | - Величина цены спроса: - |
- Величина цены предложения: - |
FACC AG INH.AKT. | - EUR | 24.09.2025 | Call |
GlobeNewswire
27.02
Ideal Protein Launches Whitepaper Unveiling Synergistic Approach to Enhance GLP-1 Medication Outcome...
GlobeNewswire
25.02
Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corpo...
GlobeNewswire
21.02
Marius Pharmaceuticals Unveils New Corporate Website and Announces Longevity & Endocrinology Advisor...
GlobeNewswire
18.02
Published Data in The Lancet Diabetes & Endocrinology Highlights Unique Efficacy Benefits of Sotagli...
GlobeNewswire
14.02
Volta Medical Artificial Intelligence-guided Cardiac Ablation Procedure Improves Treatment of Atrial...
GlobeNewswire
31.01
New Truveta study highlights patterns of discontinuation and reinitiation of GLP-1 RA medications
GlobeNewswire
26.08.2024
Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024
GlobeNewswire
14.08.2024
19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. Georg...
GlobeNewswire
13.08.2024
Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Expansion of the Phase 2b MOVE-IT Study of ...
GlobeNewswire
12.08.2024
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
08.08.2024
Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and ...
GlobeNewswire
31.07.2024
BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
GlobeNewswire
28.07.2024
Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alz...
GlobeNewswire
18.07.2024
HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in ...
GlobeNewswire
17.07.2024
Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mil...
GlobeNewswire
10.07.2024
Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Desig...
GlobeNewswire
09.07.2024
New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference
GlobeNewswire
08.07.2024
Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weigh...
GlobeNewswire
17.06.2024
Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Init...
GlobeNewswire
12.06.2024
Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspect...
GlobeNewswire
10.06.2024
Clinical ink Appoints Dr. Nicholas Alp, MD PhD FACC as Chief Medical Officer
GlobeNewswire
05.06.2024
Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница
